genedrive (LON:GDR) Shares Pass Below 50-Day Moving Average – Here’s Why

genedrive plc (LON:GDRGet Free Report)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 2.21 ($0.03) and traded as low as GBX 2 ($0.03). genedrive shares last traded at GBX 2 ($0.03), with a volume of 3,627,680 shares traded.

genedrive Price Performance

The company has a 50 day simple moving average of GBX 2.21 and a 200 day simple moving average of GBX 2.36. The company has a quick ratio of 5.52, a current ratio of 4.60 and a debt-to-equity ratio of 0.35. The company has a market capitalization of £11.36 million, a price-to-earnings ratio of -0.56 and a beta of -0.04.

genedrive (LON:GDRGet Free Report) last announced its quarterly earnings results on Friday, November 29th. The company reported GBX (4.70) (($0.06)) earnings per share for the quarter. genedrive had a negative return on equity of 191.22% and a negative net margin of 1,412.18%. As a group, research analysts predict that genedrive plc will post 209.9999867 EPS for the current year.

Insider Buying and Selling

In other genedrive news, insider Ian David Gilham purchased 225,000 shares of the firm’s stock in a transaction that occurred on Friday, December 20th. The shares were acquired at an average cost of GBX 2 ($0.03) per share, for a total transaction of £4,500 ($5,663.94). 14.75% of the stock is owned by corporate insiders.

genedrive Company Profile

(Get Free Report)

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.

Further Reading

Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.